Show items per page
Elements: 6
Page 1 on 1
 TitleAuthors / EditorsDate
add to browser selection
IL28B polymorphisms do not predict response to therapy in chronic hepatitis C with HCV genotype 5 Antaki, Nabil; Bibert, Stéphanie; Kebbewar, Kamel; Asaad, Fouad; ... Negro, Francesco 2012
add to browser selection
Long-term effects of treatment and response in patients with chronic hepatitis C on quality of life. An international, multicenter, randomized, controlled study Bezemer, Geert; Van Gool, Arthur R; Verheij-Hart, Elke; Hansen, Bettina E; ... de Knegt, Robert J 2012
add to browser selection
Vaniprevir with pegylated interferon alpha-2a and ribavirin in treatment-naïve patients with chronic hepatitis C: a randomized phase II study Manns, Michael P; Gane, Edward; Rodriguez-Torres, Maribel; Stoehr, Albrecht; ... Negro, Francesco 2012
add to browser selection
Hépatite C chronique : traitement actuel et perspectives Negro, Francesco 2011
add to browser selection
Swiss multicenter study evaluating the efficacy, feasibility and safety of peginterferon-alfa-2a and ribavirin in patients with chronic hepatitis C in official opiate substitution programs Fried, Ronald; Monnat, Martine; Seidenberg, André; Oppliger, Robert; ... Huber, Milo 2008
add to browser selection
Lack of evidence for ribavirin-induced bone loss Trombetti, Andrea; Giostra, Emiliano; Mentha, Gilles; Negro, Francesco; Rizzoli, René 2002